Expression monitoring of downstream genes in the BRCA1 pathway
US6258536A · kind A · utility
15Cited by
5References
32Claims
0Family size
Inventors
Key dates
| Filing date | Dec 1, 1998 |
| Grant date | Jul 10, 2001 |
| Priority date | — |
| Expiry date | Dec 1, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/6809
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Analysis of the genes whose expression is affected by BRCA1 has identified a set of genes, each of which is up- or down-regulated by BRCA1. Each of these genes, alone or in groups, can be used to determine the mutational status of a BRCA1 gene, to determine whether a particular allelic variant affects BRCA1 function, to diagnose neoplasia, and to help identify candidate drugs which may be useful as anti-neoplastic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.